K.CollinsM
17 Since the dosage of GLP-1 agonists across multiple dosages and in patients with different body mass indices has not been examined, alcohol reduction across medication levels and in various populations would need to be studied for successful incorporation of their use in a diverse population
Hahn T, Zhelnova E, Sucheston L, et al
Eli Lilly and Novo Nordisk each hold a roughly 20% weighting in the ETF, per Roundhill's website as of Friday
GLP-1 drugs linked to lower rates of some cancers July 16, 2024 Source: Wang, et al, JAMA Network Open, July 5, 2024 LINK Obesity is associated with increased risk of multiple cancers, including breast cancer, colorectal cancer, and endometrial cancer
Step 2: Titrate Your Dosage